Infantile hypertrophic pyloric stenosis (IHPS) is the most common surgical cause of nonbilious vomiting in infancy, affecting 1–4 per 1,000 live births, with a 4–5:1 male predominance. [1-2] It typically presents between 3 and 8 weeks of age with progressive, projectile, nonbilious vomiting caused by hypertrophy of the pyloric muscle leading to gastric outlet obstruction. [1] Definitive treatment is Ramstedt pyloromyotomy after preoperative fluid and electrolyte correction. [3-4]
1. History
- Onset and progression: Nonbilious, nonbloody vomiting that becomes progressively projectile over days to weeks, typically starting at 2–4 weeks of age [5-6]
- Timing: Vomiting occurs shortly after feeds; the infant appears hungry immediately after vomiting ("hungry vomiter")
- Feeding history: Type of feeding (breast vs. bottle); volume and frequency; formula changes attempted
- Weight trajectory: Failure to gain weight or weight loss; compare to birth weight [7]
- Stool and urine output: Decreased wet diapers and stool frequency suggest dehydration
- Duration of symptoms: Longer symptom duration correlates with more severe electrolyte derangements — hypokalemia, hypochloremia, and hypercapnia rates increase significantly with delays >10 days [8]
- Medication exposure: Ask specifically about macrolide antibiotics (erythromycin, azithromycin) given to the infant or breastfeeding mother in the first 2 weeks of life [9-11]
2. Alarm Features
- Bilious (green) vomiting — this is NOT pyloric stenosis; consider malrotation with midgut volvulus (surgical emergency) [7][12]
- Bloody emesis — suggests mucosal injury, Mallory-Weiss tear, or alternative diagnosis
- Lethargy, poor responsiveness — may indicate severe dehydration, metabolic alkalosis, or sepsis [1]
- Abdominal distension — suggests distal obstruction rather than pyloric stenosis
- Fever — atypical for pyloric stenosis; consider infectious etiologies (UTI, meningitis, sepsis)
- Apnea or respiratory depression — can occur with severe metabolic alkalosis (compensatory hypoventilation); 5% of IHPS patients develop preoperative respiratory problems, with risk increasing with higher bicarbonate levels [13]
- Bulging fontanelle or increasing head circumference — consider raised intracranial pressure [14]
3. Medications
- Macrolide antibiotics are the most important medication association:
- Erythromycin in the first 14 days of life: aOR 13.3 (95% CI 6.80–25.9) for IHPS [11]
- Azithromycin in the first 14 days of life: aOR 8.26 (95% CI 2.62–26.0) [11]
- Risk persists at 15–42 days of life but is lower (erythromycin aOR 4.10; azithromycin aOR 2.98) [11]
- Maternal macrolide use in the first 2 weeks postpartum (while breastfeeding) also associated with increased risk (RR 3.49) [15]
- The FDA label for erythromycin carries a specific warning about IHPS, with a dose-response effect: 5.1% risk at 8–14 days of use, 10% at 15–21 days [9]
- No specific medications treat IHPS — management is surgical
- Preoperative: IV fluids (D5 NS or D5 ½NS with KCl) for resuscitation
- Avoid general anesthesia until electrolytes are corrected (risk of perioperative apnea with uncorrected alkalosis) [13]
4. Diet
- NPO once diagnosis is suspected and surgical consultation is obtained
- Preoperative: Maintain NPO with IV fluid resuscitation
- Postoperative feeding: Ad libitum feeding is now recommended — associated with shorter time to goal feeds and decreased length of stay without increased readmission rates [16-18]
- Meta-analysis showed ad libitum feeding reduced LOS by ~4.7 hours compared to structured feeding [16]
- Discharge criteria: tolerating 3 consecutive full-strength feeds [17]
- Postoperative emesis is common (30–47%) regardless of feeding strategy and does not indicate surgical failure [18]
- Breast milk or standard formula; no special formula required postoperatively
5. Review of Systems
- GI: Character of vomiting (projectile vs. effortless), bilious vs. nonbilious, blood in emesis, stool pattern, constipation
- Constitutional: Weight loss, irritability, lethargy, fever
- GU: Urine output (dehydration assessment)
- Respiratory: Apnea, tachypnea (compensatory hypoventilation in alkalosis or respiratory distress from aspiration)
- Neuro: Alertness, fontanelle fullness, seizures (to exclude intracranial pathology)
6. Collateral History and Family History
- Family history of pyloric stenosis — strong familial aggregation; polygenic inheritance pattern [4][19]
- If a mother had pyloric stenosis, risk to male offspring is ~20%; to female offspring ~7%
- If a father had pyloric stenosis, risk to male offspring is ~5%; to female offspring ~2.5%
- Birth history: Gestational age (preterm delivery is a risk factor), birth weight, delivery method (cesarean section associated with increased risk) [19]
- Feeding history from caregiver: Exact onset of vomiting, progression, number of providers seen
- Medication history: Any antibiotics given to infant or breastfeeding mother
7. Risk Factors
- Male sex (4–5:1 male-to-female ratio) [1][19]
- First-born infant [1][19]
- White/Caucasian ethnicity (highest incidence) [1]
- Family history of pyloric stenosis [4][6]
- Macrolide antibiotic exposure in first 6 weeks of life [10-11][15]
- Maternal smoking during pregnancy [19]
- Preterm delivery [19]
- Small for gestational age [19]
- Cesarean section delivery [19]
- Bottle-fed or mixed-fed infants (75.7% in one series) [20]
8. Differential Diagnosis
- Gastroesophageal reflux (GER/GERD) — most common mimic; effortless regurgitation rather than projectile vomiting; infant typically thriving; serum bicarbonate ≥29 or chloride ≤98 strongly favors pyloric stenosis over GER [21]
- Malrotation with midgut volvulus — cannot miss; bilious vomiting, abdominal distension; surgical emergency with risk of bowel necrosis within hours [7][12]
- Pylorospasm — transient, self-limited; can mimic pyloric stenosis on ultrasound (double-track sign) but without muscle hypertrophy [12]
- Gastroenteritis — acute onset, diarrhea, fever, usually self-limited [12]
- Formula intolerance / cow's milk protein allergy — bloody stools, eczema, atopic features [5]
- Intussusception — intermittent colicky pain, currant jelly stools; uncommon <3 months [7][12]
- Increased intracranial pressure — bulging fontanelle, increasing head circumference, lethargy, seizures [14]
- Inborn errors of metabolism — lethargy, poor feeding, seizures; metabolic acidosis (not alkalosis) [12]
- UTI / sepsis — fever, irritability; especially in infants <3 months [7]
- Adrenal insufficiency (CAH) — vomiting with hyperkalemia, hyponatremia, ambiguous genitalia in females
9. Past Medical History
- Gestational age and birth weight
- NICU stay or perinatal complications
- Prior episodes of vomiting and workup
- Congenital anomalies — coexisting defects found in ~20% of IHPS cases [8]
- Previous antibiotic use (especially macrolides)
- Immunization history (recent rotavirus vaccine can cause transient vomiting)
10. Physical Exam
- Vital signs: Tachycardia (dehydration), normal temperature (fever atypical), assess weight against birth weight
- General: Alert but may be irritable or lethargic if severely dehydrated; assess hydration status (mucous membranes, skin turgor, fontanelle, capillary refill, tears)
- Abdomen:
- Palpable "olive" — firm, mobile, 1–2 cm mass in the right upper quadrant/epigastrium; best palpated after vomiting or with gastric decompression via NG tube. Sensitivity 73.5%, specificity 97.5% (LR+ 33). However, the frequency of palpable olive has decreased significantly with earlier diagnosis [22-23]
- Visible gastric peristaltic waves — left-to-right peristalsis across the upper abdomen after feeding
- Abdomen is typically soft, non-distended, non-tender
- Fontanelle: Sunken suggests dehydration; bulging raises concern for intracranial pathology
11. Lab Studies
- Basic metabolic panel (BMP) — the essential initial lab:
- Classic finding: hypochloremic, hypokalemic metabolic alkalosis [1]
- However, normal electrolytes are the most common finding at initial presentation in the modern era (62% have normal bicarbonate) [24]
- Longer symptom duration → more severe derangements [8][25]
- Serum chloride is the most sensitive and specific single electrolyte marker:
- Cl ≤98 mmol/L: PPV 0.97 for pyloric stenosis vs. GER [21]
- Cl ≤97 mmol/L predicts need for ≥2 fluid boluses [26]
- Cl <85 mmol/L predicts need for ≥3 boluses [26]
- Serum bicarbonate ≥29 mmol/L: PPV 0.96 for pyloric stenosis vs. GER [21]
- Blood gas (venous or capillary): Confirms metabolic alkalosis; assess for compensatory respiratory acidosis (elevated pCO₂)
- BUN/Creatinine: Elevated BUN suggests dehydration (prerenal azotemia)
- Urinalysis: Paradoxical aciduria may be present in severe cases (kidneys excrete H⁺ to retain K⁺) [1]
- Labs used to determine surgical readiness: Chloride ≥100, bicarbonate ≤30, potassium ≥3.5 are commonly used thresholds before proceeding to anesthesia [26-27]
12. Imaging
- Abdominal ultrasound — gold standard and first-line imaging:
- Sensitivity and specificity approaching 100% [12][28]
- Diagnostic criteria:
- Pyloric muscle thickness (PMT) ≥3 mm (100% sensitive, 99% specific) [28-29]
- Pyloric canal length (PCL) ≥15 mm (100% sensitive, 97% specific) [28]
- Combining PMT ≥3.0 mm + PCL ≥14.5 mm: sensitivity 95%, specificity 99% [29]
- Additional findings: failure of gastric contents to pass through the pylorus on dynamic imaging; "target sign" on transverse view; "cervix sign" on longitudinal view [30]
- Point-of-care ultrasound (POCUS): Sensitivity 96.6–97.7%, specificity 94.0–94.1%; reduces ED length of stay by ~1 hour compared to radiology-performed US [22][31]
- Upper GI series: Rarely needed; may show "string sign" (elongated pyloric channel), "shoulder sign," or "double-track sign"; reserved for equivocal ultrasound [12]
- Abdominal radiograph: Nonspecific; may show distended, gas-filled stomach with paucity of distal bowel gas ("caterpillar sign" from visible peristalsis); not diagnostic
13. Special Tests
- No validated clinical scoring system exists specifically for pyloric stenosis
- POCUS at bedside is the most impactful special test in the ED — can be performed by emergency physicians with accuracy comparable to radiology [2][31-32]
- NG tube decompression: Therapeutic (relieves gastric distension) and can facilitate physical exam (easier to palpate olive after decompression)
14. ECG
- Not routinely indicated unless severe electrolyte derangements are present
- Hypokalemia may cause: ST depression, decreased T-wave amplitude, prominent U waves, prolonged QT [33]
- Metabolic alkalosis may cause: decreased T-wave amplitude [33]
- Obtain ECG if K⁺ <3.0 mmol/L or significant metabolic alkalosis (pH >7.55) before anesthesia induction
15. Assessment
- Typical presentation: 3–6 week old, first-born male with progressive nonbilious projectile vomiting, hungry after emesis, weight loss or poor gain, +/- palpable olive, confirmed by ultrasound
- Atypical presentations to recognize:
- Normal electrolytes (majority of modern presentations) [24]
- Absent palpable olive (increasingly common with earlier diagnosis) [23]
- Presentation <2 weeks or >8 weeks of age
- Female infants (lower index of suspicion may delay diagnosis)
- Severity stratification: Based on degree of dehydration and electrolyte derangement — determines urgency and duration of preoperative resuscitation
- Complications of delayed diagnosis: Severe dehydration, metabolic alkalosis with compensatory hypoventilation/apnea, aspiration pneumonia, failure to thrive [1][13]
16. Treatment Plan
Initial stabilization (ED)
- IV access, NPO
- Fluid resuscitation: D5 NS at 1.5× maintenance rate [17][26]
- If Cl ≤97 mmol/L: give 2 boluses of 20 mL/kg NS separated by 1 hour before rechecking labs [26]
- If Cl <85 mmol/L: give 3 boluses of 20 mL/kg NS separated by 1 hour [26]
- Add KCl 20–40 mEq/L to maintenance fluids once urine output is established
- NG tube if significant gastric distension or ongoing emesis
- Correct electrolytes to surgical readiness: Cl ≥100, HCO₃ ≤30, K ≥3.5 [26]
Definitive treatment
- Ramstedt pyloromyotomy — open or laparoscopic [1][3]
- Laparoscopic: potentially earlier return to full feeds, better cosmesis, but slightly higher risk of incomplete pyloromyotomy [1]
- Open (via right upper quadrant or periumbilical incision): well-established, low complication rate [4]
- Complications: mucosal perforation (1–2%), incomplete pyloromyotomy (<1%), wound infection [1]
Postoperative
- Ad libitum feeding starting ~2 hours postoperatively is recommended [16-17]
- Expect some postoperative emesis (30–47%) — this is normal and self-limited [18]
- Discharge after tolerating 3 consecutive full-strength feeds [17]
- Median postoperative LOS: ~22 hours [17]
17. Disposition
- All patients with confirmed pyloric stenosis require admission for preoperative resuscitation and pyloromyotomy
- Pediatric surgery consultation should be obtained as soon as diagnosis is confirmed or strongly suspected
- Transfer to a facility with pediatric surgery if not available
- Median time from arrival to surgery: ~19.5 hours (driven by resuscitation time) [17]
- Readmission rate: ~3.6% within 30 days, most within 72 hours of discharge [17]
- Re-operation for incomplete pyloromyotomy is rare (~0.3%) [17]
18. Follow Up / Return Precautions
- Follow-up: Pediatric surgery in 1–2 weeks; PCP within 2–3 days of discharge
- Return precautions — instruct caregivers to return for:
- Persistent projectile vomiting >24 hours after surgery (concern for incomplete pyloromyotomy)
- Bilious (green) vomiting at any time
- Signs of dehydration: <3 wet diapers in 24 hours, sunken fontanelle, lethargy
- Fever >100.4°F (wound infection)
- Wound redness, swelling, or drainage
- Expected recovery: Some postoperative emesis is normal for 24–48 hours; full feeds typically tolerated within 12–18 hours [17]
- Prognosis: Excellent — pyloromyotomy is curative with near-zero mortality in the modern era; no long-term GI sequelae expected [4]
References
1. Open Versus Laparoscopic Pyloromyotomy for Pyloric Stenosis. — Staerkle RF, Lunger F, Fink L, et al. The Cochrane Database of Systematic Reviews. 2021.
2. Point-of-Care Ultrasound in Pediatric Clinical Care. — McLario DJ, Sivitz AB. JAMA Pediatrics. 2015.
3. Contemporary Management of Pyloric Stenosis. — Jobson M, Hall NJ. Seminars in Pediatric Surgery. 2016.
4. Infantile Hypertrophic Pyloric Stenosis: A Review. — Spicer RD. The British Journal of Surgery. 1982.
5. Gastroesophageal Reflux in Infants and Children: Diagnosis and Treatment. — Antono B, Dotson A. American Family Physician. 2025.
6. Hypertrophic pyloric stenosis in twins; genetic or environmental factors. — Gezer HÖ, Oguzkurt P, Temiz A, Hicsonmez A. Clinical Genetics. 2015.
7. Acute Abdominal Pain in Children: Evaluation and Management. — Buel KL, Wilcox J, Mingo PT. American Family Physician. 2024.
8. The Clinical Features of Infantile Hypertrophic Pyloric Stenosis in Chinese Han Population: Analysis From 1998 to 2010. — Feng Z, Nie Y, Zhang Y, et al. PloS One. 2014.
9. FDA Drug Label. — Updated date: 2025-09-25. Food and Drug Administration.
10. Association Between Exposure to Macrolides and the Development of Infantile Hypertrophic Pyloric Stenosis: A Systematic Review and Meta-Analysis. — Abdellatif M, Ghozy S, Kamel MG, et al. European Journal of Pediatrics. 2019.
11. Azithromycin in Early Infancy and Pyloric Stenosis. — Eberly MD, Eide MB, Thompson JL, Nylund CM. Pediatrics. 2015.
12. ACR Appropriateness Criteria® Vomiting in Infants. — Expert Panel on Pediatric Imaging, Alazraki AL, Rigsby CK, et al. Journal of the American College of Radiology : JACR. 2020.
13. Respiratory Problems Owing to Severe Metabolic Alkalosis in Infants Presenting With Hypertrophic Pyloric Stenosis. — van den Bunder FAIM, van Woensel JBM, Stevens MF, et al. Journal of Pediatric Surgery. 2020.
14. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. — Rosen R, Vandenplas Y, Singendonk M, et al. Journal of Pediatric Gastroenterology and Nutrition. 2018.
15. Use of Macrolides in Mother and Child and Risk of Infantile Hypertrophic Pyloric Stenosis: Nationwide Cohort Study. — Lund M, Pasternak B, Davidsen RB, et al. BMJ. 2014.
16. Feeding Post-Pyloromyotomy: A Meta-Analysis. — Sullivan KJ, Chan E, Vincent J, et al. Pediatrics. 2016.
17. Hypertrophic Pyloric Stenosis Protocol: A Single Center Study. — Cruz-Centeno N, Fraser JA, Stewart S, et al. The American Surgeon. 2023.
18. Safety and Benefit of Ad Libitum Feeding Following Laparoscopic Pyloromyotomy: Retrospective Comparative Trial. — Hong Y, Okolo F, Morgan K, et al. Pediatric Surgery International. 2022.
19. Pre- And Perinatal Risk Factors for Pyloric Stenosis and Their Influence on the Male Predominance. — Krogh C, Gørtz S, Wohlfahrt J, et al. American Journal of Epidemiology. 2012.
20. Epidemiological and Clinical Characteristics of 304 Patients With Infantile Hypertrophic Pyloric Stenosis in Anhui Province of East China, 2012-2015. — Li J, Gao W, Zhu JM, Zuo W, Liu X. The Journal of Maternal-Fetal & Neonatal Medicine : The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2018.
21. Diagnostic Aids in the Differentiation of Pyloric Stenosis From Severe Gastroesophageal Reflux During Early Infancy: The Utility of Serum Bicarbonate and Serum Chloride. — Smith GA, Mihalov L, Shields BJ. The American Journal of Emergency Medicine. 1999.
22. Vomiting, Pyloric Mass, and Point-of-Care Ultrasound: Diagnostic Test Accuracy for Hypertrophic Pyloric Stenosis-a Meta-Analysis. — Hom J, Lam SHF, Delaney KM, Koos JA, Kunkov S. The Journal of Emergency Medicine. 2023.
23. Recent Changes in the Features of Hypertrophic Pyloric Stenosis. — Bakal U, Sarac M, Aydin M, Tartar T, Kazez A. Pediatrics International : Official Journal of the Japan Pediatric Society. 2016.
24. Electrolyte Profile of Pediatric Patients With Hypertrophic Pyloric Stenosis. — Tutay GJ, Capraro G, Spirko B, Garb J, Smithline H. Pediatric Emergency Care. 2013.
25. The Spectrum of Serum Electrolytes in Hypertrophic Pyloric Stenosis. — Touloukian RJ, Higgins E. Journal of Pediatric Surgery. 1983.
26. Optimizing Fluid Resuscitation in Hypertrophic Pyloric Stenosis. — Dalton BG, Gonzalez KW, Boda SR, et al. Journal of Pediatric Surgery. 2016.
27. A Randomized Trial to Assess Advancement of Enteral Feedings Following Surgery for Hypertrophic Pyloric Stenosis. — Markel TA, Scott MR, Stokes SM, Ladd AP. Journal of Pediatric Surgery. 2017.
28. Evaluation of Ultrasonographic Parameters in the Diagnosis of Pyloric Stenosis Relative to Patient Age and Size. — Iqbal CW, Rivard DC, Mortellaro VE, Sharp SW, St Peter SD. Journal of Pediatric Surgery. 2012.
29. Evaluating the Validity of Ultrasound in Diagnosing Hypertrophic Pyloric Stenosis: A Cross-Sectional Diagnostic Accuracy Study. — Vinycomb T, Vanhaltren K, Pacilli M, Ditchfield M, Nataraja RM. ANZ Journal of Surgery. 2021.
30. Ultrasound Diagnosis of Hypertrophic Pyloric Stenosis: Real-Time Application and the Demonstration of a New Sonographic Sign. — Ball TI, Atkinson GO, Gay BB. Radiology. 1983.
31. Feasibility of Point-of-Care Ultrasound for Diagnosing Hypertrophic Pyloric Stenosis in the Emergency Department. — Park JS, Byun YH, Choi SJ, et al. Pediatric Emergency Care. 2021.
32. Feasibility of Emergency Physician Diagnosis of Hypertrophic Pyloric Stenosis Using Point-of-Care Ultrasound: A Multi-Center Case Series. — Malcom GE, Raio CC, Del Rios M, Blaivas M, Tsung JW. The Journal of Emergency Medicine. 2009.
33. Metabolic disturbances for the electrophysiologist. — Lee JZ, Asirvatham SJ. Journal of Cardiovascular Electrophysiology. 2019.